Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Comment by Breakthoroughon Dec 05, 2020 1:19am
169 Views
Post# 32043247

RE:RE:RE:RE:RE:Comparison with STR-002

RE:RE:RE:RE:RE:Comparison with STR-002Of course. And the distribution of the 10 is 3 over 12 months, 6 over 6 months, 1 below 6 months. The total number of 4 that have reached 12 months include 3 ongoing. It means thay only 7 of the ongoing 10 could (in the best of cases) add to these four. The final number will be between 11 (36%) and 4 (13%). A different thing is that in the dose-expansion trial the numbers become a bit better, due to the optimization of dose and the inclussion of less heavily pre-treated parients. They anticipate preliminary data by the 2nd half of 2021, and a meeting with the FDA in the 2nd half of 2021.
<< Previous
Bullboard Posts
Next >>